Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors-Reference-Cited by-同舟云学术

Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors

Published:2014-10-27 Issue:4 Volume:4 Page:287-294
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Cox Donna S.¹,Allred Alicia¹,Zhou YanYan¹,Infante Jeffrey R.²,Gordon Michael S.³,Bendell Johanna²,Jones Suzanne²,Burris Howard²,Orford Keith¹

Affiliation:

1. GlaxoSmithKline; Collegeville PA USA

2. Sarah Cannon Research Institute; Nashville TN USA

3. Pinnacle Oncology Hematology; Scottsdale AZ USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Reference7 articles.

1. Relative bioavailability of liquid and tablet formulations of the antiparasitic moxidectin;Korth-Bradley;Clin Pharm Drug Dev.,2012

2. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations, US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER); December 2002

3. Evaluation of the effects of food on the single-dose pharmacokinetics of trametinib, a first-in-class MEK inhibitor, in patients with cancer;Cox;J Clin Pharmacol.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms;Pharmaceutics;2022-12-17

2. The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models;Clinical Cancer Research;2022-11-02

3. Trametinib for Refractory Chylous Effusions and Systemic Complications in Children with Noonan Syndrome;The Journal of Pediatrics;2022-09

4. Tyrosine kinase inhibitors via nasogastric tube may resolve severe ileus secondary to melanoma: A case report;Current Problems in Cancer: Case Reports;2022-06

5. Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update;Pharmaceutics;2022-05-10